{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:17:33Z","timestamp":1785525453955,"version":"3.56.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["Award"],"award-info":[{"award-number":["Award"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health (US)-Fogarty International","award":["D43TW009607"],"award-info":[{"award-number":["D43TW009607"]}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12 HD000850"],"award-info":[{"award-number":["K12 HD000850"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The World Health Organization (WHO) has endorsed the next-generation Xpert MTB\/RIF Ultra (Ultra) cartridge, and Uganda is currently transitioning from the older generation Xpert MTB\/RIF (Xpert) cartridge to Ultra as the initial diagnostic test for pulmonary tuberculosis (TB). We assessed the diagnostic accuracy of Ultra for pulmonary TB among adults in Kampala, Uganda.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We sampled adults referred for Xpert testing at two hospitals and a health center over a 12-month period. We enrolled adults with positive Xpert and a random 1:1 sample with negative Xpert results. Expectorated sputum was collected for Ultra, and for solid and liquid culture testing for Xpert-negative patients. We measured sensitivity and specificity of Ultra overall and by HIV status, prior history of TB, and hospitalization, in reference to Xpert and culture results. We also assessed how classification of results in the new \u201ctrace\u201d category affects Ultra accuracy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 698 participants included, 211 (30%) were HIV-positive and 336 (48%) had TB. The sensitivity of Ultra was 90.5% (95% CI 86.8\u201393.4) and specificity was 98.1% (95% CI 96.1\u201399.2). There were no significant differences in sensitivity and specificity by HIV status, prior history of TB or hospitalization. Xpert and Ultra results were concordant in 670 (96%) participants, with Ultra having a small reduction in specificity (difference 1.9, 95% CI 0.2 to 3.6,<jats:italic>p<\/jats:italic>=0.01). When \u201ctrace\u201d results were considered positive for all patients, sensitivity increased by 2.1% (95% CI 0.3 to 3.9,<jats:italic>p<\/jats:italic>=0.01) without a significant reduction in specificity (\u2212\u20090.8, 95% CI \u2212\u20090.3 to 2.0,<jats:italic>p<\/jats:italic>=0.08).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>After 1 year of implementation, Ultra had similar performance to Xpert. Considering \u201ctrace\u201d results to be positive in all patients increased case detection without significant loss of specificity. Longitudinal studies are needed to compare the benefit of greater diagnoses to the cost of overtreatment.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-020-05727-8","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T13:28:51Z","timestamp":1610371731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The transition to Xpert MTB\/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda"],"prefix":"10.1186","volume":"21","author":[{"given":"A.","family":"Andama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jaganath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Crowder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Asege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nakaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Katumba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mukwatamundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mwebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. F.","family":"Semitala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Worodria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Joloba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Somoskovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cattamanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"5727_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.12688\/gatesopenres.12842.1","volume":"2","author":"D Cazabon","year":"2018","unstructured":"Cazabon D, Pande T, Kik S, Van Gemert W, Sohn H, Denkinger C, et al. Market penetration of Xpert MTB\/RIF in high tuberculosis burden countries: A trend analysis from 2014\u20132016. Gates Open Res. 2018;2:35.","journal-title":"Gates Open Res"},{"issue":"4","key":"5727_CR2","doi-asserted-by":"publisher","first-page":"e00812","DOI":"10.1128\/mBio.00812-17","volume":"8","author":"S Chakravorty","year":"2017","unstructured":"Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, et al. The new Xpert MTB\/RIF ultra: improving detection of mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. MBio. 2017;8(4):e00812\u20137.","journal-title":"MBio."},{"issue":"1","key":"5727_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","volume":"18","author":"SE Dorman","year":"2018","unstructured":"Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, et al. Xpert MTB\/RIF ultra for detection of mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018;18(1):76\u201384.","journal-title":"Lancet Infect Dis"},{"key":"5727_CR4","unstructured":"World Health Organization. WHO meeting report of a technical expert consultation: Non-inferiority analysis of Xpert MTB\/RIF Ultra compared to Xpert MTB\/RIF. Available at: https:\/\/www.who.int\/tb\/publications\/2017\/XpertUltra\/en\/. Last accessed 4 Aug 2019.2017."},{"key":"5727_CR5","unstructured":"World Health Organization. Global tuberculosis report 2019.2019 14 Dec 2019. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329368\/9789241565714-eng.pdf?ua=1."},{"key":"5727_CR6","unstructured":"Global Laboratory Initiative. Planning for country transition to Xpert\u00ae MTB\/RIF Ultra Cartridges. Available at: http:\/\/www.stoptb.org\/wg\/gli\/assets\/documents\/gli_ultra.pdf. Last Accessed 28 Jan 2020."},{"issue":"1","key":"5727_CR7","doi-asserted-by":"publisher","first-page":"114892","DOI":"10.1016\/j.diagmicrobio.2019.114892","volume":"96","author":"A Andama","year":"2020","unstructured":"Andama A, Jaganath D, Crowder R, Asege L, Nakaye M, Katumba D, et al. Accuracy and incremental yield of urine Xpert MTB\/RIF ultra versus determine TB-LAM for diagnosis of pulmonary tuberculosis. Diagn Microbiol Infect Dis. 2020;96(1):114892.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"5727_CR8","doi-asserted-by":"publisher","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","volume":"6","author":"JF Cohen","year":"2016","unstructured":"Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6(11):e012799.","journal-title":"BMJ Open"},{"key":"5727_CR9","unstructured":"Stop TB Partnership Global Laboratory Initiative. Mycobacteriology Laboratory Manual. Available at: http:\/\/www.stoptb.org\/wg\/gli\/assets\/documents\/gli_mycobacteriology_lab_manual_web.pdf. Last accessed 4 Aug 2019.2014."},{"key":"5727_CR10","volume-title":"Lateral flow urine Lipoarabinomannan assay (LF-LAM): for the diagnosis and screening of active tuberculosis in people living with HIV","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Lateral flow urine Lipoarabinomannan assay (LF-LAM): for the diagnosis and screening of active tuberculosis in people living with HIV. Geneva: World Health Organization; 2016. Available at https:\/\/www.who.int\/tb\/publications\/factsheet_lf_lam.pdf. Last accessed 27 Jan 2020."},{"key":"5727_CR11","volume-title":"WHO meeting report of a technical expert consultation: non-inferiority analysis of Xpert MTB\/RIF ultra compared to Xpert MTB\/RIF","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. WHO meeting report of a technical expert consultation: non-inferiority analysis of Xpert MTB\/RIF ultra compared to Xpert MTB\/RIF. Geneva: World Health Organization; 2017. Available at: https:\/\/www.who.int\/tb\/publications\/2017\/XpertUltra\/en\/. Last accessed 18 Jan 2020."},{"key":"5727_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijid.2019.09.016","volume":"90","author":"M Zhang","year":"2020","unstructured":"Zhang M, Xue M, J-q H. Diagnostic accuracy of the new Xpert MTB\/RIF ultra for tuberculosis disease: a preliminary systematic review and meta-analysis. Int J Infect Dis. 2020;90:35\u201345.","journal-title":"Int J Infect Dis"},{"key":"5727_CR13","doi-asserted-by":"publisher","unstructured":"Berhanu RH, David A, da Silva P, Shearer K, Sanne I, Stevens W, Scott L.\u00a0 Performance of Xpert MTB\/RIF, Xpert Ultra, and Abbott RealTime MTB for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Burden Setting. J Clin Microbiol. 2018;56(12):e00560-18. https:\/\/doi.org\/10.1128\/jcm.00560-18.","DOI":"10.1128\/jcm.00560-18"},{"key":"5727_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijid.2020.03.025","volume":"95","author":"A Esmail","year":"2020","unstructured":"Esmail A, Tomasicchio M, Meldau R, Makambwa E, Dheda K. Comparison of Xpert MTB\/RIF (G4) and Xpert ultra, including trace readouts, for the diagnosis of pulmonary tuberculosis in a TB and HIV endemic setting. Int J Infect Dis. 2020;95:246\u201352.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"5727_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S2213-2600(19)30370-4","volume":"8","author":"H Mishra","year":"2020","unstructured":"Mishra H, Reeve BWP, Palmer Z, Caldwell J, Dolby T, Naidoo CC, et al. Xpert MTB\/RIF ultra and Xpert MTB\/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study. Lancet Respir Med. 2020;8(4):368\u201382.","journal-title":"Lancet Respir Med"},{"key":"5727_CR16","doi-asserted-by":"publisher","first-page":"105876","DOI":"10.1016\/j.rmed.2020.105876","volume":"162","author":"GR Pereira","year":"2020","unstructured":"Pereira GR, Barbosa MS, Dias NJD, FDF d S, Rauber KA, Silva DR. Evaluation of Xpert MTB\/RIF Ultra performance for pulmonary tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil. Respir Med. 2020;162:105876.","journal-title":"Respir Med"},{"issue":"2","key":"5727_CR17","doi-asserted-by":"crossref","first-page":"e01717","DOI":"10.1128\/JCM.01717-18","volume":"57","author":"O Opota","year":"2019","unstructured":"Opota O, Zakham F, Mazza-Stalder J, Nicod L, Greub G, Jaton K. Added Value of Xpert MTB\/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting. J Clin Microbiol. 2019;57(2):e01717\u20138.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"5727_CR18","doi-asserted-by":"publisher","first-page":"e1002472","DOI":"10.1371\/journal.pmed.1002472","volume":"14","author":"EA Kendall","year":"2017","unstructured":"Kendall EA, Schumacher SG, Denkinger CM, Dowdy DW. Estimated clinical impact of the Xpert MTB\/RIF ultra cartridge for diagnosis of pulmonary tuberculosis: a modeling study. PLoS Med. 2017;14(12):e1002472.","journal-title":"PLoS Med"},{"key":"5727_CR19","unstructured":"World Health Organization. Uganda Tuberculosis Profile. Available at https:\/\/extranet.who.int\/sree\/Reports?op=Replet&name=\/WHO_HQ_Reports\/G2\/PROD\/EXT\/TBCountryProfile&ISO2=UG&outtype=PDF. Accessed 12 Feb 2020."},{"key":"5727_CR20","first-page":"Cd009593","volume":"6","author":"DJ Horne","year":"2019","unstructured":"Horne DJ, Kohli M, Zifodya JS, Schiller I, Dendukuri N, Tollefson D, et al. Xpert MTB\/RIF and Xpert MTB\/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2019;6:Cd009593.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05727-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05727-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05727-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T06:52:27Z","timestamp":1670741547000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05727-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5727"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05727-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants completed a written informed consent, and the study was approved by the Makerere University School of Medicine Research and Ethics Committee, the Uganda National Council for Science and Technology and the University of California San Francisco Committee on Human Research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}